Dicerna Pharmaceuticals (NASDAQ:DRNA) Earnings Information
Dicerna Pharmaceuticals last issued its quarterly earnings results on February 25th, 2021. The biopharmaceutical company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of $0.11 by $0.60. The firm earned $40.96 million during the quarter, compared to the consensus estimate of $81.82 million. Dicerna Pharmaceuticals has generated ($1.76) earnings per share over the last year. Dicerna Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Dicerna Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Dicerna Pharmaceuticals (NASDAQ:DRNA) Earnings Estimates
2021 EPS Consensus Estimate: ($0.32)
Dicerna Pharmaceuticals (NASDAQ DRNA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)